日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

YKT6 Promotes Bladder Cancer Progression by Stabilizing β-catenin Through USP7-Mediated Deubiquitination

YKT6通过USP7介导的去泛素化作用稳定β-catenin,从而促进膀胱癌进展。

Tu, Sheng; Du, Wenzhi; Luo, Yongwen; Shi, Jiageng; Liu, Tianyun; Ji, Meng; Xiong, Kangping; Chen, Siming; Zhou, Fenfang; Li, Mingxing; Yu, Jingtian; Wang, Gang; Ju, Lingao; Zhang, Yi; Xiao, Yu; Wang, Xinghuan; Qian, Kaiyu

Epigenetic insights into minimal residual disease detection in cancer

表观遗传学见解在癌症微小残留病灶检测中的应用

Ju, Lingao; Wang, Gang; Xu, Zilin; Xiang, Wan; Peng, Hongwei; Yu, Mengxue; Li, Shenjuan; Zhang, Yi; Qian, Kaiyu; Xiao, Yu

Evolution of Cancer Metastases via Lineage Trans-Differentiation

癌症转移的演化:谱系转分化

Xiao, Yu; Jin, Wan; Chen, Fangjin; Qian, Kaiyu; Ju, Lingao; Zhang, Yi

Tracking single-cell evolution using clock-like chromatin accessibility loci

利用时钟样染色质可及性位点追踪单细胞进化

Xiao, Yu; Jin, Wan; Ju, Lingao; Fu, Jie; Wang, Gang; Yu, Mengxue; Chen, Fangjin; Qian, Kaiyu; Wang, Xinghuan; Zhang, Yi

RNF112 Facilitates Ubiquitin-Mediated Degradation of c-Myc, Suppressing Proliferation, Migration and Lipid Synthesis in Bladder Cancer.

RNF112 促进泛素介导的 c-Myc 降解,抑制膀胱癌细胞的增殖、迁移和脂质合成

Xiong Kangping, Chen Siming, Xu Huimin, Tu Sheng, Weng Hong, Wang Yejinpeng, Li Mingxing, Yu Jingtian, Qian Kaiyu, Ju Lingao, Zhang Yi, Xiao Yu, Wang Xinghuan, Wang Gang

DLGAP5 enhances bladder cancer chemoresistance by regulating glycolysis through MYC stabilization.

DLGAP5 通过 MYC 稳定作用调节糖酵解,从而增强膀胱癌的化疗耐药性

Deng Zhao, Zhou Fenfang, Li Mingxing, Jin Wan, Yu Jingtian, Wang Gang, Qian Kaiyu, Ju Lingao, Zhang Yi, Xiao Yu, Wang Xinghuan

FBXW7/GSK3β-mediated proline-rich 11 degradation promotes oxidative DNA damage and inhibits tumor progression in renal cell carcinoma.

FBXW7/GSK3β介导的富含脯氨酸的11降解促进氧化性DNA损伤,并抑制肾细胞癌的肿瘤进展

Chen Siming, Xiong Kangping, Liu Jianmin, Yao Shijie, Li Mingxing, Yu Jingtian, Wang Gang, Tu Sheng, Jin Wan, Shi Jiageng, Xiao Yu, Zhang Yi, Qian Kaiyu, Ju Lingao, Wang Xinghuan

USP43 promotes gemcitabine resistance by regulating cholesterol homeostasis through E2F1 stabilization in bladder cancer

USP43通过稳定膀胱癌中的E2F1来调节胆固醇稳态,从而促进吉西他滨耐药。

Li, Mingxing; Liu, Tianyun; Shi, Jiageng; Zhou, Fenfang; Deng, Zhao; Luo, Yongwen; Tu, Sheng; Jiang, Wenyu; Wang, Gang; Qian, Kaiyu; Zhang, Yi; Xiao, Yu; Wang, Xinghuan; Liu, Tongzu; Ju, Lingao

Concurrent DNA hypomethylation and epigenomic reprogramming driven by androgen receptor binding in bladder cancer oncogenesis

膀胱癌发生过程中,雄激素受体结合驱动的DNA低甲基化和表观基因组重编程同时发生。

Xiao, Yu; Ju, Lingao; Jin, Wan; Peng, Hongwei; Zhou, Zongning; Yu, Mengxue; Xu, Zilin; Wang, Gang; Qian, Kaiyu; Zhang, Yi; Wang, Xinghuan

Elucidating the pathogenesis of bladder cancer through single-cell chromatin accessibility and DNA methylation analysis

通过单细胞染色质可及性和DNA甲基化分析阐明膀胱癌的发病机制

Xiao, Yu; Ju, Lingao; Wang, Gang; Jin, Wan; Peng, Hongwei; Zhou, Zongning; Yu, Mengxue; Zhang, Yi; Qian, Kaiyu; Wang, Xinghuan